Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• Crisis as Opportunity: Rheumatology Prospects Boom Amid Shortage
• AI and the Rheumatologist: An Opportunity for Better Care Leonard H. Calabrese, DO
• Ace the Case: A 52-Year-Old Patient With Rheumatoid Arthritis Who Had an Inadequate Response to Methotrexate and a Tumor Necrosis Factor Inhibitor
• FDA: Xeljanz 10 mg Increases Risk for Blood Clots, Death in RA
• FDA Adds Boxed Warning to Febuxostat for Increased Mortality Risk
• Gottlieb Resignation Raises Questions About the Future of Biosimilars in the US
• Ankylosing Spondylitis Increases Risk for Venous Thromboembolism
• Etanercept, Combination Therapy Superior to Methotrexate Alone in PsA
• Majority of Rheumatologists Dissatisfied With Pediatric-to-adult Care Transition
• Most Patients Experience Symptoms for 1 to 5 Years Prior to Hip Replacement
• Nearly 1 in 4 Patients With Gout Report Sleep Disorders
• Project Data Establish National Norm Empathy Scores for Osteopathic Medical Students
• Siblings of Patients With RA at Higher Risk for Acute Cardiac Syndrome
• TNF Inhibitor Dose Reduction Noninferior to Full Dose in Ankylosing Spondylitis
• Vectra Test Superior to DAS28-CRP in Predicting Radiographic Progression in RA
• Women, Less Educated Face Worse SpA Disease Activity, Physical Function
• Patients With Ankylosing Spondylitis Had Low Dislocation Rate After THA
• What’s in a Name? How Wegener’s Granulomatosis Became GPA
• Visual Aids May Improve Patient Perception of Risk in Knee Replacement
• Holding Abatacept Before Hip, Knee Surgery May Not Improve Outcomes
• Knee Pain not Linked to Daily Walking Levels in Mild, Moderate OA
• Landmark $270 Million Opioid Lawsuit Settlement Opens Door for Dozens of Pending Cases
• Myalgia, Arthralgia Linked to Checkpoint Inhibitors Vary in Severity, Treatment
• Sustained Smoking Cessation Reduces Risk for Seropositive RA
• Tramadol Linked to Higher Mortality Rates in Older Patients With OA